Skip to NavigationSkip to content

Synthetic, non-intoxicating CBD analogue treats seizures in rats

Published on 31/05/19 at 10:02am

A synthetic, non-intoxicating cannabidiol (CBD)-analogue is effective at treating seizures in rats, according to researchers at the University of California, Davis.

The molecule, 8,9-Dihydrocannabidiol (H2CBD) is a synthetic molecule which is structurally similar to the CBD. Mascal’s lab developed H2CBD from commercially available chemicals.

The UC Davis researchers tested H2CBD against CBD, in rats with induced seizures. Both drugs were found to be equally effective in treating seizures in rats.

“It's a much safer drug than CBD, with no abuse potential and doesn't require the cultivation of hemp,” said Mark Mascal, professor in the UC Davis Department of Chemistry.

Mascal is now working with colleagues to carry out further clinical trials. The teams findings were published in the journal Scientific Reports.

Louis Goss

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches